Search
for
Sort by
Research 241–270 of 655
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- THE PEDIATRICIAN AND THE SEXUALLY ACTIVE ADOLESCENT
- Anabolic-androgenic steroids. Mechanism of action and clinical effects
- INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
- Endocrinologia e Medicina Estética Ed. X
- The skin and obesity
- Pomen prehrane pri hormonski terapiji za potrditev spola
- A Case of Telogen Effluvium as COVID Sequelae
- Cutaneous Lupus Erythematosus
- Injectable Dual‐Crosslinked Poly(oligo(Ethylene Glycol) Methacrylate) Hydrogels Inspired by Mussel Adhesion for Cutaneous Wound Healing and Functional Tissue Regeneration
- The Effect of Ferritin, Vitamin D, and Some Hormonal and Biochemical Parameters on Patients with Female-pattern Hair Loss after COVID-19 Infection
- A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS‐CoV‐2 vaccine
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Post-finasteride syndrome: An emerging clinical problem
- Vitamin E-induced coagulopathy in a young patient: a case report
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Gender Differences in Response to COVID-19 Infection and Vaccination
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- EP1410 - ECE_1202 - Individualized endocrine care in non-binary individuals: efficacy, safety, and long-term outcomes of microdosing and selective hormone modulators
- A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata
- POS1510-HPR NUTRITIONAL STATUS AND DIETARY INTAKE ASSESSMENT IN PREGNANT WOMEN WITH RHEUMATIC DISEASES
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Vaccines, adjuvants and autoimmunity